Jeremy B. Hayden
General Counsel, Plus Therapeutics.
Companies
- Sight Sciences, Inc.General counsel Jul 14, 2021 to now1
- Plus TherapeuticsGeneral counsel Aug 12, 2015 to Mar 17, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Sight Sciences, Inc. SGHT357,037 shares3$3.0M at $8.29Jul 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 6, 2026Sold 12,733 shares at $5.51 of Sight Sciences, Inc.3
- Apr 6, 2026Sold 13,761 shares at $3.55 of Sight Sciences, Inc.4
- Feb 3, 2026Granted 115,920 shares of Sight Sciences, Inc.5
- Jan 16, 2026Sold 6,308 shares at $6.62 of Sight Sciences, Inc.6
- Jan 6, 2026Sold 1,785 shares at $7.48 of Sight Sciences, Inc.7
- Jan 5, 2026Sold 9,385 shares at $7.82 of Sight Sciences, Inc.7
- Nov 25, 2025Sold 44,850 shares at $8.08 of Sight Sciences, Inc.8
- Nov 25, 2025Exercised options 7,290 shares at $1.96 of Sight Sciences, Inc.8
- Nov 25, 2025Exercised options 37,560 shares at $1.96 of Sight Sciences, Inc.8
- Nov 12, 2025Sold 3,150 shares at $8.01 of Sight Sciences, Inc.9
- Nov 12, 2025Exercised options 710 shares at $1.96 of Sight Sciences, Inc.9
- Nov 12, 2025Exercised options 2,440 shares at $1.96 of Sight Sciences, Inc.9
- Oct 3, 2025Sold 9,731 shares at $3.27 of Sight Sciences, Inc.10
- Jul 3, 2025Sold 9,160 shares at $4.17 of Sight Sciences, Inc.11
- Apr 2, 2025Sold 9,395 shares at $2.31 of Sight Sciences, Inc.12
- Mar 11, 2025Granted 139,785 shares of Sight Sciences, Inc.13
- Jan 17, 2025Sold 6,922 shares at $2.78 of Sight Sciences, Inc.14
- Jan 8, 2025Sold 1,810 shares at $3.26 of Sight Sciences, Inc.15
- Jan 3, 2025Sold 4,864 shares at $3.52 of Sight Sciences, Inc.16
- Oct 1, 2024Sold 4,878 shares at $6.08 of Sight Sciences, Inc.17
- Jul 2, 2024Sold 5,055 shares at $6.21 of Sight Sciences, Inc.18
- Apr 3, 2024Sold 4,893 shares at $5.08 of Sight Sciences, Inc.19
- Feb 14, 2024Granted 151,869 shares of Sight Sciences, Inc.20
- Jan 17, 2024Sold 4,538 shares at $5.16 of Sight Sciences, Inc.21
- Jan 3, 2024Shares withheld for tax 1,227 shares at $5.17 of Sight Sciences, Inc.22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARPlus Therapeutics, General counsel
- 3
- 4SEC EDGARForm 4 filed Apr 9, 2026
- 5SEC EDGARForm 4 filed Feb 5, 2026
- 6SEC EDGARForm 4 filed Jan 21, 2026
- 7SEC EDGARForm 4 filed Jan 6, 2026
- 8SEC EDGARForm 4 filed Nov 26, 2025
- 9SEC EDGARForm 4 filed Nov 14, 2025
- 10SEC EDGARForm 4 filed Oct 3, 2025
- 11SEC EDGARForm 4 filed Jul 7, 2025
- 12SEC EDGARForm 4 filed Apr 3, 2025
- 13SEC EDGARForm 4 filed Mar 13, 2025
- 14SEC EDGARForm 4 filed Jan 21, 2025
- 15SEC EDGARForm 4 filed Jan 10, 2025
- 16SEC EDGARForm 4 filed Jan 6, 2025
- 17SEC EDGARForm 4 filed Oct 3, 2024
- 18SEC EDGARForm 4 filed Jul 3, 2024
- 19SEC EDGARForm 4 filed Apr 4, 2024
- 20SEC EDGARForm 4 filed Feb 16, 2024
- 21SEC EDGARForm 4 filed Jan 19, 2024
- 22SEC EDGARForm 4 filed Jan 5, 2024